Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | F2 | P00734 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | PLG | P00747 | 4/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | PLAU | P00749 | 4/20 | 0.35 |
| ▸ | F10 | P00742 | 2/20 | 0.35 |
| ▸ | PLAT | P00750 | 2/20 | 0.35 |
| ▸ | ST14 | Q9Y5Y6 | 2/20 | 0.35 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.35 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.35 |
| ▸ | HPN | P05981 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-(Ethoxycarbonyl)Piperazine SCHEMBL7137671 | 0.72 | PLAU (0.65) | F2PLGPLAUF10PLAT | |
| Dl-Phenylalanine SCHEMBL27693339 | 0.72 | ALPI (0.54) | KMT2AKDM4EPOLBALDH1A1TSHR | |
| N-(Ethoxycarbonyl)Piperazine SCHEMBL3660147 | 0.70 | PLAU (0.58) | F2PLGPLAUF10PLAT | |
| SCHEMBL7058121 | 0.66 | PLG (0.43) | F2PLGPLAUF10ST14 | |
| SCHEMBL4678247 | 0.66 | KMT2A (0.56) | KMT2AKDM4EPOLBLMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL4678245 | 0.65 | KMT2A (0.55) | KMT2AKDM4EPOLBLMNAALDH1A1 | |
| N-(Ethoxycarbonyl)Piperazine SCHEMBL28781643 | 0.64 | KMT2A (0.50) | KMT2AKDM4EPOLBLMNAALDH1A1 | |
| SCHEMBL15921435 | 0.64 | NOS3 (0.56) | KMT2AKDM4EPOLBLMNAALDH1A1 | |
| SCHEMBL202930 | 0.64 | NOS3 (0.56) | KMT2AKDM4EPOLBLMNAALDH1A1 | |
| SCHEMBL4265888 | 0.63 | HTR6 (0.43) | KMT2AF2KDM4EPOLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6680320-B2 | ANTITUMOR AGENTS | WILEX AG (DE) | 2004-01-20 | — | — | US | disclosed |
| US-20030013723-A1 | Antitumor agents | WILEX AG | 2003-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030013723-A1 | Antitumor agents | DNPEP, PLAU, ENPEP | KMT2A 1823/4885F2 1620/4885KDM4E 3747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.